{'fraction_non_alphanumeric': 0.015424164524421594, 'fraction_numerical': 0.017994858611825194, 'mean_word_length': 5.182539682539683, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates.

OBJECTIVES
Resistance to azole antifungal drugs in Aspergillus fumigatus that is not mediated by target gene mutations is now common in some locations. The aim of this study was to investigate possible new mechanisms of resistance in non-target resistance.


METHODS
Twelve azole-resistant A. fumigatus isolates previously shown not to carry mutations in cyp51A were tested to determine whether the alternative cyp51B gene was overexpressed.


RESULTS
Of 12 isolates one showed overinduction of cyp51B after exposure to itraconazole and another showed high constitutive expression of cyp51B.


CONCLUSIONS
cyp51B overexpression is a possible azole resistance mechanism in A. fumigatus.